Some industry-funded clinical trials show signs of being designed to market drugs rather than to test them for their safety and effectiveness. Detecting these studies remains difficult.
Data centers need powerful chips, while smartphones need chips that are energy efficient. A supply chain scholar explains why chipmakers' focus on the former comes at the expense of the latter.
A case involving the potential dangers of glyphosate, the active ingredient in the weed killer sold as Roundup, could affect broader consumer-protection efforts.
Business culture has long embraced grit as a winning value. But modern examples show that companies will do better if they acknowledge mistakes quickly and pivot.